TerSera therapeutics News and Activities

Acquisition, funding and merger involving TerSera therapeutics.

• Esteve has announced the acquisition of TerSera therapeutics  (posted on January 27 2026).

View the org chart displaying its 12 main executives

Most searched biographies at TerSera therapeutics

• Edward Donovan, Chief Executive Officer
• Chris Smith, Director
• Dean Mihas, Director

Create your alert
to follow the executive moves at TerSera therapeutics.

TerSera therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by TerSera therapeutics

• TerSera | News & Insights
• TerSera | News & Insights
• TerSera | News & Insights

Social media about TerSera therapeutics

• TerSera therapeutics on Wikipedia, Google News & Yahoo Finance
• TerSera therapeutics on LinkedIn, X (Twitter) & YouTube